Work for Aurinia Pharmaceuticals Inc.?

Claim Your Profile

Aurinia Pharmaceuticals Inc. Logo Image

Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. Banner Image

About Aurinia Pharmaceuticals Inc.

51-200 Employees
Based in Victoria, British Columbia

Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis and Dry Eye Syndrome. The company is headquartered in Victoria, British Columbia, its U.S. commercial hub in Rockville, MD, and focuses its development efforts globally.

Ticker:
AUP
Exchange:
TSX (See More TSX Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol